Special Issue

Topic: Advances in the Management of Cardiac Amyloidosis

A Special Issue of Vessel Plus

ISSN 2574-1209 (Online)

Submission deadline: 30 Apr 2021

Guest Editor(s)

Prof. Livi Ugolino
Department of Cardiothoracic Surgery, Azienda Sanitaria Universitaria Integrata, Udine, Italy; Department of Medical Area, University of Udine, Udine, Italy.
Prof. Gianfranco Sinagra
Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.

Special Issue Introduction

Systemic amyloidosis is a rare haematologic disorder where fibrils of misfolded proteins acquire a b-pleated sheet conformation, form amyloid fibril proteins, and begin to infiltrate tissues leading to organ failure. At least 30 different proteins have been reported to produce amyloid fibrils, but two types are more capable of affecting the heart, such as light-chain (AL) amyloidosis and transthyretin-related (TTR) amyloidosis, as hereditary or acquired form. The heart involvement due to the extracellular protein fibril deposition in the myocardium could appear with several manifestations, ranging from conduction-system disease to atrial fibrillation, sudden cardiac death or restrictive cardiomyopathy and heart failure, thus conditioning the stage and prognosis of the entire disease. Recently, significant progress has been made in the treatment of amyloid cardiomyopathy, and these promising results have already opened new chances for these patients. This Special Issue has two main objectives: (1) to provide the readers, through thoughtful review articles, a comprehensive state-of-art of the current knowledge about cardiac amyloidosis; (2) to stimulate researchers to share their experience in this field, since the overall contributions could open new borders in such rare diseases, as cardiac amyloidosis.

Keywords

Cardiac amyloidosis, light chain cardiac amyloidosis, transthyretin amyloid cardiomyopathy, wild type TTR amyloidosis, hereditary TTR amyloidosis, heart failure, heart transplantation

Submission Deadline

30 Apr 2021

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/vp/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=vp&SpecialIssueId=546
Submission Deadline: 30 Apr 2021
Contacts: Grace Zheng, Assistant Editor, grace@vpjournal.net

Published Articles

Cardiac amyloidosis: the pathologist’s point of view

Open Access Review DOI: 10.20517/2574-1209.2022.05 16 Oct 2022
Views: Downloads:
Download PDF

Clinical translation of genetic testing in TTR Amyloidosis: genotype-phenotype correlations, management of asymptomatic carriers and familial screening

Open Access Review DOI: 10.20517/2574-1209.2021.74 29 Sep 2022
Views: Downloads:
Download PDF

Heart transplantation in cardiac amyloidosis

Open Access Review DOI: 10.20517/2574-1209.2021.126 31 Jul 2022
Views: Downloads:
Download PDF

The changing perspective on cardiac amyloidosis in the modern era

Open Access Editorial DOI: 10.20517/2574-1209.2021.143 31 Jul 2022
Views: Downloads:
Download PDF

Grey zones in the supportive treatments of cardiac amyloidosis

Open Access Review DOI: 10.20517/2574-1209.2021.134 31 May 2022
Views: Downloads:
Download PDF

Cardiac amyloidosis: a changing epidemiology with open challenges

Open Access Review DOI: 10.20517/2574-1209.2021.106 12 May 2022
Views: Downloads:
Download PDF

Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis

Open Access Review DOI: 10.20517/2574-1209.2021.87 4 Mar 2022
Views: Downloads:
Download PDF

Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis

Open Access Original Article DOI: 10.20517/2574-1209.2021.86 16 Feb 2022
Views: Downloads:
Download PDF

Disclosing the cardiomyopathic substrate within the heart muscles in amyloidosis by cardiac magnetic resonance: diagnostic and prognostic implications

Open Access Review DOI: 10.20517/2574-1209.2021.81 16 Feb 2022
Views: Downloads:
Download PDF

Recent advances in the pharmacotherapy of TTR amyloidosis of the heart

Open Access Review DOI: 10.20517/2574-1209.2021.76 24 Oct 2021
Views: Downloads:
Download PDF

Interpreting signals from the peripheral nerve in amyloidosis: a call for action

Open Access Review DOI: 10.20517/2574-1209.2021.69 20 Jul 2021
Views: Downloads:
Download PDF

Nuclear medicine techniques for the diagnosis of cardiac amyloidosis: the state of the art

Open Access Review DOI: 10.20517/2574-1209.2021.67 4 Jul 2021
Views: Downloads:
Download PDF
Vessel Plus
ISSN 2574-1209 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/